Flex Biomedical gets $866,000 from investors

Flex Biomedical gets $866,000 from investors

Flex Biomedical, a Madison company developing treatments for orthopedic diseases, has received $866,000 from investors, the Wisconsin State Journal reports. The money will be used to advance the Flex Polymer, a synthetic polymer designed to treat osteoarthritis. (WISCONSIN STATE JOURNAL, 1/28)

To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.

Pin It on Pinterest